Definitive Healthcare will release Q3 financial results on November 6, 2025, followed by a conference call.
Quiver AI Summary
Definitive Healthcare Corp. announced that it will release its financial results for the third quarter of 2025 on November 6, 2025, after the market closes. The company will hold a conference call and webcast at 5:00 PM ET to discuss the results, which will be accessible via their Investor Relations website. Participants can join the call through a live dial-in for both domestic and international callers. A replay of the call will be available until December 6, 2025. Definitive Healthcare focuses on providing healthcare commercial intelligence through data, analytics, and SaaS solutions to help clients navigate and succeed in the healthcare industry.
Potential Positives
- Definitive Healthcare will provide quarterly financial results, demonstrating transparency and accountability to investors.
- The scheduled conference call allows for direct engagement between the company and its stakeholders, fostering better communication.
- The company reinforces its position as an industry leader by showcasing its mission to transform healthcare commercial intelligence.
- The availability of a rebroadcast of the conference call extends access to information for investors and interested parties beyond the live event.
Potential Negatives
- e
FAQ
When will Definitive Healthcare report its third quarter financial results?
Definitive Healthcare will report its third quarter financial results on November 6, 2025, after market close.
What time is the conference call for the financial results?
The conference call will take place at 5:00 PM ET on November 6, 2025.
How can I access the live audio webcast of the conference call?
The live audio webcast will be available on Definitive Healthcare's Investor Relations website.
What is the number to dial for the conference call?
The dial-in number for the conference call is 877-358-7298 for domestic calls and +1-848-488-9244 for international calls.
When will the replay of the conference call be available?
The replay will be available shortly after the call until December 6, 2025, at 800-645-7964 or 757-849-6722.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DH Hedge Fund Activity
We have seen 66 institutional investors add shares of $DH stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 3,136,876 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,233,816
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,088,952 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,246,912
- BLACKROCK, INC. removed 969,126 shares (-23.7%) from their portfolio in Q2 2025, for an estimated $3,779,591
- VANGUARD GROUP INC removed 903,689 shares (-23.6%) from their portfolio in Q2 2025, for an estimated $3,524,387
- WHETSTONE CAPITAL ADVISORS, LLC removed 869,275 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,390,172
- D. E. SHAW & CO., INC. added 538,008 shares (+61.8%) to their portfolio in Q2 2025, for an estimated $2,098,231
- RENAISSANCE TECHNOLOGIES LLC added 403,691 shares (+134.7%) to their portfolio in Q2 2025, for an estimated $1,574,394
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DH Analyst Ratings
Wall Street analysts have issued reports on $DH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for $DH, check out Quiver Quantitative's $DH forecast page.
$DH Price Targets
Multiple analysts have issued price targets for $DH recently. We have seen 2 analysts offer price targets for $DH in the last 6 months, with a median target of $4.7.
Here are some recent targets:
- David Grossman from Stifel set a target price of $6.0 on 08/08/2025
- Kash Rangan from Goldman Sachs set a target price of $3.4 on 05/12/2025
Full Release
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
A live audio webcast of the event will be available on the Definitive Healthcare’s Investor Relations website at https://ir.definitivehc.com/ .
A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly after the conclusion of the call, a replay of this conference call will be available through December 6, 2025 at 800-645-7964 or 757-849-6722. The replay passcode is 1765#.
About Definitive Healthcare
At Definitive Healthcare, our mission is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS products and solutions create new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at
definitivehc.com
.
Media Contact:
Bethany Swackhamer
[email protected]
Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
[email protected]
Source: Definitive Healthcare Corp.
